Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: New York City house mice as potential reservoirs for pathogenic bacteria and AMR determinants

PROVIDER: PRJNA445852 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6903320_1.fastq.gz	Fastqsanger.gz
	SRR6903320_2.fastq.gz	Fastqsanger.gz
	SRR6903330_1.fastq.gz	Fastqsanger.gz
	SRR6903330_2.fastq.gz	Fastqsanger.gz
	SRR6903340_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 220

Similar Datasets

Project description:New York City wild house mouse virome

| PRJNA555205 | ENA

Smith&Moore2004 - The SIR model for the spread of HongKong Flu

Project description:This is the SIR model for disease spread of the Hong Kong flu in New York City in the late 1960's.

2022-01-27 | BIOMD0000001045 | BioModels

Project description:Urban Coyotes in New York City

| PRJNA857904 | ENA

urban metagenome

Project description:New York City MTA subway samples Metagenome

| PRJNA271013 | ENA

Project description:New York City Routine Pathogen Surveillance Sequencing Data

| PRJNA1020074 | ENA

Universal antimicrobial resistance detection from clinical bacterial isolates using proteomics

Project description:Antimicrobial resistance (AMR) is an increasing challenge for therapy and management of bacterial infections. Currently, antimicrobial resistance detection relies on phenotypic assays, which are performed independently of species identification. On the contrary, phenotypic prediction from molecular data using genomics is gaining interest in clinical microbiology and might become a serious alternative in the future. Although, in general protein analysis should be superior to genomics for phenotypic prediction, no untargeted proteomics workflow specifically related to AMR detection has been proposed so far. In this study, we present a universal proteomics workflow to detect the bacterial species and antimicrobial resistance related proteins in the absence of secondary antibiotic cultivation in less than 4 h from a primary culture. The method was validated using a sample cohort of 7 bacterial species and 11 AMR determinants represented by 13 protein isoforms which resulted in a sensitivity of 92 % (100 % with vancomycin inference) and a specificity of 100 % with respect to AMR determinants. This proof-of concept study demonstrates the high potential of untargeted proteomics for clinical microbiology.

2021-11-25 | PXD022425 | Pride

Identification of small molecule inhibitors of the Pathogen Box against Vibrio cholerae

Project description:Antimicrobial resistance (AMR) has become a serious public and economic threat. The rate of bacteria acquiring AMR surpasses the rate of new antibiotics discovery, projecting more deadly AMR infections in the future. The Pathogen Box is an open-source library of drug-like compounds that can be screened for antibiotic activity. We have screened molecules of the Pathogen Box against Vibrio cholerae, the cholera-causing pathogen, and successfully identified two compounds, MMV687807 and MMV675968, that inhibit growth. RNA-seq analyses of V. cholerae after incubation with each compound revealed that both compounds affect cellular functions on multiple levels including carbon metabolism, iron homeostasis, and biofilm formation. In addition, whole-genome sequencing analysis of spontaneous resistance mutants identified an efflux system that confers resistance to MMV687807. We also identified that the dihydrofolate reductase is the likely target of MMV675968 suggesting it acts as an analog of trimethoprim but with a minimum inhibitory concentration (MIC) 14-fold lower than trimethoprim in molar concentration. In summary, these two compounds that effectively inhibit V. cholerae and other bacteria may lead to the development of new antibiotics for better treatment of the cholera disease.

2021-11-18 | GSE185596 | GEO

air metagenome

Project description:New York City Subway Air Survey for 16S rRNA

| PRJNA169671 | ENA

Project description:Carbapenem-resistant Enterobacterales from a New York City Hospital

| PRJNA1088550 | ENA

Bacteria in New England house dust

Project description:Bacteria in New England house dust

| PRJEB5724 | ENA